Compartment syndrome caused by computed tomography contrast infiltration seen on a Tc-99m methylene diphosphonate bone scan.
A 72-year-old man was hospitalized for transurethral resection of bladder cancer. Two days after the procedure, the patient continued to have gross hematuria and a computed tomography (CT) scan of the abdomen and pelvis with intravenous contrast was performed to check the integrity of the resection site. Later that day, the patient underwent technetium-99m methylene diphosphonate (MDP) bone scintigraphy to investigate the possibility of bone metastasis. The bone scan showed no signs of metastasis but did reveal increased uptake of the left hand and forearm on the opposite side of the injection site.
Gerard
Perry S
PS
Division of Nuclear Medicine, Maimonides Medical Center, Brooklyn, NY 11219, USA. gperry@optonline.net
Gerczuk
Paul Z
PZ
Idupuganti
Raghu
R
Patnana
Madhavi
M
Geller
Matthew D
MD
D000368:Aged; D001132:Arm; D003161:Compartment Syndromes / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D006801:Humans; D007267:Injections / Q000009:adverse effects*; D008297:Male; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects*; D013669:Technetium Tc 99m Medronate / Q000008:administration & dosage / Q000009:adverse effects*; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D001749:Urinary Bladder Neoplasms / Q000473:pathology
D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate